65 related articles for article (PubMed ID: 4686106)
1. In vivo release of H 3 -dopamine from the brain during the administration of haloperidol.
Von Voigtlander PF; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):223-32. PubMed ID: 4686106
[No Abstract] [Full Text] [Related]
2. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
Gudelsky GA; McCall RB; Chiueh CC; Moore KE
Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):653-60. PubMed ID: 4456497
[No Abstract] [Full Text] [Related]
3. Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.
Chiueh CC; Moore KE
Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):189-99. PubMed ID: 4811449
[No Abstract] [Full Text] [Related]
4. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
Van Rossum JM
Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
[No Abstract] [Full Text] [Related]
5. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
Von Voigtlander PF; Moore KE
J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
[No Abstract] [Full Text] [Related]
6. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
McKenzie GM; Szerb JC
J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
[No Abstract] [Full Text] [Related]
7. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
Pehek EA
J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
[TBL] [Abstract][Full Text] [Related]
8. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
[TBL] [Abstract][Full Text] [Related]
9. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol].
Shevchenko TP; Tolpyshev BA; Zban' LN
Eksp Klin Farmakol; 1993; 56(3):15-7. PubMed ID: 8219980
[TBL] [Abstract][Full Text] [Related]
10. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
[No Abstract] [Full Text] [Related]
11. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
Chiueh CC; Moore KE
J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
[No Abstract] [Full Text] [Related]
12. Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses.
Snyder SH; Aghajanian GK; Matthysse S
Neurosci Res Program Bull; 1972 Nov; 10(4):430-45. PubMed ID: 4663824
[No Abstract] [Full Text] [Related]
13. Rapid development of hypersensitivity and hyposensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in CNS.
Cools AR
Adv Biochem Psychopharmacol; 1980; 24():215-22. PubMed ID: 6996442
[No Abstract] [Full Text] [Related]
14. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
Vetulani J
Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
[No Abstract] [Full Text] [Related]
15. Effects of long-term treatment of haloperidol on D2 dopamine receptors in various areas of rat brain.
Watanabe M; Ohtakeno S; Watanabe H; Mamiya G; Ichinowatari N
Yakubutsu Seishin Kodo; 1993 Oct; 13(5):315-9. PubMed ID: 8266741
[TBL] [Abstract][Full Text] [Related]
16. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
[TBL] [Abstract][Full Text] [Related]
18. Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels.
Juorio AV; Danielson TJ
Eur J Pharmacol; 1978 Jul; 50(1):79-82. PubMed ID: 354941
[TBL] [Abstract][Full Text] [Related]
19. [Morphochemical changes in brain structures during hypofunction of the dopaminergic system and their correction with tuftsin].
Gershtei'n LM; Dobrynina MT; Sergutina AV; Rakhmanova VI
Biull Eksp Biol Med; 1996 Oct; 122(10):381-3. PubMed ID: 9081430
[No Abstract] [Full Text] [Related]
20. Biochemical effects of haloperidol in different species.
Himwich WA; Davis JM; Leiner KY; Stout M
Biol Psychiatry; 1970 Oct; 2(4):315-9. PubMed ID: 5478592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
